{"title":"Aripiprazole intestinal side effects in flies","authors":"Jorge Ferreira","doi":"10.1038/s41684-025-01555-y","DOIUrl":null,"url":null,"abstract":"<p>Aripiprazole, a third-generation antipsychotic, acts as a dopamine partial agonist and is generally better tolerated than older antipsychotics by humans. However, many patients report gastrointestinal side effects, the mechanisms of which remain unclear. A study in <i>Disease Models & Mechanisms</i> used <i>Drosophila melanogaster</i> to model the potential gut toxicity of aripiprazole, exploring the conserved drug metabolism pathways and well-characterized intestinal system. Oral aripiprazole exposure in flies caused mitochondrial dysfunction, leading to elevated reactive oxygen species (ROS) and activation of the JNK (c-Jun N-terminal kinase) signaling pathway, linked to cellular stress and death, specifically via the fly orthologue <i>basket</i> (bsk). Chronic JNK activation disrupted intestinal homeostasis, triggered apoptosis and led to gut tissue degeneration. Here, the gene <i>puckered</i>, a negative regulator of JNK signaling, was upregulated, confirming pathway engagement. Notably, supplementation with antioxidants mitigated these toxic effects. These findings link aripiprazole-induced gut toxicity to mitochondrial dysfunction and ROS-dependent JNK activation and suggest a mechanistic basis for the drug’s gastrointestinal side effects observed in patients.</p><p><b>Original reference:</b> Hurcomb, J.D. et al. <i>Dis. Model. & Mech</i>. <b>18</b>, dmm052180 (2025)</p>","PeriodicalId":17936,"journal":{"name":"Lab Animal","volume":"22 1","pages":"114-114"},"PeriodicalIF":5.9000,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lab Animal","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.1038/s41684-025-01555-y","RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Aripiprazole, a third-generation antipsychotic, acts as a dopamine partial agonist and is generally better tolerated than older antipsychotics by humans. However, many patients report gastrointestinal side effects, the mechanisms of which remain unclear. A study in Disease Models & Mechanisms used Drosophila melanogaster to model the potential gut toxicity of aripiprazole, exploring the conserved drug metabolism pathways and well-characterized intestinal system. Oral aripiprazole exposure in flies caused mitochondrial dysfunction, leading to elevated reactive oxygen species (ROS) and activation of the JNK (c-Jun N-terminal kinase) signaling pathway, linked to cellular stress and death, specifically via the fly orthologue basket (bsk). Chronic JNK activation disrupted intestinal homeostasis, triggered apoptosis and led to gut tissue degeneration. Here, the gene puckered, a negative regulator of JNK signaling, was upregulated, confirming pathway engagement. Notably, supplementation with antioxidants mitigated these toxic effects. These findings link aripiprazole-induced gut toxicity to mitochondrial dysfunction and ROS-dependent JNK activation and suggest a mechanistic basis for the drug’s gastrointestinal side effects observed in patients.
Original reference: Hurcomb, J.D. et al. Dis. Model. & Mech. 18, dmm052180 (2025)
期刊介绍:
LabAnimal is a Nature Research journal dedicated to in vivo science and technology that improves our basic understanding and use of model organisms of human health and disease. In addition to basic research, methods and technologies, LabAnimal also covers important news, business and regulatory matters that impact the development and application of model organisms for preclinical research.
LabAnimal's focus is on innovative in vivo methods, research and technology covering a wide range of model organisms. Our broad scope ensures that the work we publish reaches the widest possible audience. LabAnimal provides a rigorous and fair peer review of manuscripts, high standards for copyediting and production, and efficient publication.